Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Biologics Contract Development Market, by Region, 2020-2030 (USD Billion)
1.2.2. Biologics Contract Development Market, by Source, 2020-2030 (USD Billion)
1.2.3. Biologics Contract Development Market, by Product Service, 2020-2030 (USD Billion)
1.2.4. Biologics Contract Development Market, by Disease Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biologics Contract Development Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biologics Contract Development Market Dynamics
3.1. Biologics Contract Development Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of various target diseases
3.1.1.2. Increased drug development methods by pharmaceutical companies population
3.1.1.3. Increased inclination for personalised medication by consumers
3.1.2. Market Challenges
3.1.2.1. High Cost of biologics production processes
3.1.3. Market Opportunities
3.1.3.1. Increase in the adoption of advanced technologies for biological development
3.1.3.2. Increase in the development of greater manufacturing flexibility in the biopharmaceutical sector
Chapter 4. Global Biologics Contract Development Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Biologics Contract Development Market, by Source
5.1. Market Snapshot
5.2. Global Biologics Contract Development Market by Source, Performance - Potential Analysis
5.3. Global Biologics Contract Development Market Estimates & Forecasts by Source 2020-2030 (USD Billion)
5.4. Biologics Contract Development Market, Sub Segment Analysis
5.4.1. Microbial
5.4.2. Mammalian
5.4.3. Others
Chapter 6. Global Biologics Contract Development Market, by Product Service
6.1. Market Snapshot
6.2. Global Biologics Contract Development Market by Product Service, Performance - Potential Analysis
6.3. Global Biologics Contract Development Market Estimates & Forecasts by Product Service 2020-2030 (USD Billion)
6.4. Biologics Contract Development Market, Sub Segment Analysis
6.4.1. Cell Line Development
6.4.2. Process Development
6.4.3. Others
Chapter 7. Global Biologics Contract Development Market, by Disease Indication
7.1. Market Snapshot
7.2. Global Biologics Contract Development Market by Disease Indication, Performance - Potential Analysis
7.3. Global Biologics Contract Development Market Estimates & Forecasts by Disease Indication 2020-2030 (USD Billion)
7.4. Biologics Contract Development Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Immunological Disorders
7.4.3. Cardiovascular Disorders
7.4.4. Hematological Disorders
7.4.5. Others
Chapter 8. Global Biologics Contract Development Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Biologics Contract Development Market, Regional Market Snapshot
8.4. North America Biologics Contract Development Market
8.4.1. U.S. Biologics Contract Development Market
8.4.1.1. Source breakdown estimates & forecasts, 2020-2030
8.4.1.2. Product Service breakdown estimates & forecasts, 2020-2030
8.4.1.3. Disease Indication breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Biologics Contract Development Market
8.5. Europe Biologics Contract Development Market Snapshot
8.5.1. U.K. Biologics Contract Development Market
8.5.2. Germany Biologics Contract Development Market
8.5.3. France Biologics Contract Development Market
8.5.4. Spain Biologics Contract Development Market
8.5.5. Italy Biologics Contract Development Market
8.5.6. Rest of Europe Biologics Contract Development Market
8.6. Asia-Pacific Biologics Contract Development Market Snapshot
8.6.1. China Biologics Contract Development Market
8.6.2. India Biologics Contract Development Market
8.6.3. Japan Biologics Contract Development Market
8.6.4. Australia Biologics Contract Development Market
8.6.5. South Korea Biologics Contract Development Market
8.6.6. Rest of Asia Pacific Biologics Contract Development Market
8.7. Latin America Biologics Contract Development Market Snapshot
8.7.1. Brazil Biologics Contract Development Market
8.7.2. Mexico Biologics Contract Development Market
8.8. Middle East & Africa Biologics Contract Development Market
8.8.1. Saudi Arabia Biologics Contract Development Market
8.8.2. South Africa Biologics Contract Development Market
8.8.3. Rest of Middle East & Africa Biologics Contract Development Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. WuXi Biologics
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Abzena Ltd
9.3.3. Fujifilm Diosynth Biotechnologies
9.3.4. KBI Biopharma, Inc.
9.3.5. AGC Biologics
9.3.6. Thermo Fisher Scientific Inc.
9.3.7. Curia Global, Inc.
9.3.8. Genscript
9.3.9. Bionova Scientific, Inc.
9.3.10. BioXcellence (Boehringer Ingelheim Biopharmaceuticals GmbH)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption